Advertisement

Obesity Surgery

, Volume 19, Issue 4, pp 537–537 | Cite as

Succinylcholine: A Useful Drug in Bariatric Surgery

  • Jay B. BrodskyEmail author
  • Harry J. M. Lemmens
  • John M. Morton
Letter to the Editor

Keywords

Obese Patient Tracheal Intubation Succinylcholine Vecuronium Rocuronium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

To the editor:

We read the recent article by Tejirian et al. [1], and as members of our American College of Surgeons Level 1A Center of Excellence management team, we feel that a reply is indicated. Based on a single case, they recommended avoidance of succinylcholine (SCH) in all bariatric patients. At Stanford University, we take an opposite approach and use SCH to facilitate tracheal intubation for all of our morbidly obese patients.

With its rapid onset and short duration of action, SCH is ideal for rapid sequence induction of anesthesia. This is particularly important in bariatric patients because hemoglobin desaturation occurs rapidly following apnea and intubation of the trachea must be accomplished quickly [2]. SCH’s onset is fast and its duration of action is short. Therefore, if difficulties are encountered when securing the airway, the immediate return of motor function allows the patient to resume spontaneous ventilation.

There is no way to prove or disprove the “clinical” diagnosis that SCH was responsible for their patient’s severe muscle aches. If SCH was the cause, it was an extreme presentation of a complication that is usually mild (if and when present) and of minimal clinical significance, especially in bariatric patients [3]. We have anesthetized hundreds of morbidly obese patients and thousands of other patients using SCH without ever having the serious complications they associated with its use.

As the authors’ note, once the neuromuscular reversal agent sugammadex becomes available clinically, a nondepolarizing muscle relaxant such as rocuronium or vecuronium will become a safe option to SCH. With sugammadex, reversal will be obtained immediately, effectively controlling time of paralysis. Until that time, we believe that SCH remains the drug of choice for tracheal intubation in bariatric patients.

References

  1. 1.
    Tejirian T, Lewis CE, Conner J, Jensen C, et al. Succinylcholine: a drug to avoid in bariatric surgery. Obes Surg. 2008; in press.Google Scholar
  2. 2.
    Brodsky JB, Lemmens HJM, Brock-Utne JG, et al. Morbid obesity and tracheal intubation. Anesth Analg 2002;94:732–6.CrossRefGoogle Scholar
  3. 3.
    Lemmens HJM, Brodsky JB. The dose of succinylcholine in morbid obesity. Anesth Analg 2006;102:438–42.CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2008

Authors and Affiliations

  • Jay B. Brodsky
    • 1
    Email author
  • Harry J. M. Lemmens
    • 1
  • John M. Morton
    • 2
  1. 1.Department of AnesthesiaStanford University Medical CenterStanfordUSA
  2. 2.Department of SurgeryStanford University Medical CenterStanfordUSA

Personalised recommendations